These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7708611)

  • 21. New developments in Helicobacter pylori eradication therapy.
    Pounder RE
    Scand J Gastroenterol Suppl; 1997; 223():43-5. PubMed ID: 9200305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori in peptic ulcer disease.
    Del Med J; 1994 Oct; 66(10):557-8. PubMed ID: 7958122
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori--an update.
    Axon AT
    Scand J Gastroenterol Suppl; 1994; 205():31-7. PubMed ID: 7863239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori.
    Duggan A; Williamson R
    Gut; 1998 Apr; 42(4):596-7. PubMed ID: 9616332
    [No Abstract]   [Full Text] [Related]  

  • 28. [Helicobacter and peptic ulcer: history, diagnosis and therapy--when, in whom and how?].
    Beglinger C
    Schweiz Med Wochenschr; 1994 Mar; 124(10):426-8. PubMed ID: 8153602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinico-pharmacologic considerations in Helicobacter pylori eradication therapy].
    Leiss O; Von Bergmann K
    Z Gastroenterol; 1993; 31(7-8):450-8. PubMed ID: 8379234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Helicobacter pylori infection in children].
    Martínez MJ
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():48-50. PubMed ID: 8054371
    [No Abstract]   [Full Text] [Related]  

  • 35. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of Helicobacter pylori: omeprazole in combination with antibiotics.
    Axon AT; Moayyedi P
    Scand J Gastroenterol Suppl; 1996; 215():82-9. PubMed ID: 8722389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of bismuth in gastroenterology. The ACG Committee on FDA-Related Matters. American College of Gastroenterology.
    Marshall BJ
    Am J Gastroenterol; 1991 Jan; 86(1):16-25. PubMed ID: 1986548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.